![]() Aptinyx Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders. | |||
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Evanston, US HQ Evanston, US | Locations Redwood City, US HQ Boston, US | Locations Cambridge, US HQ Smithfield, US |
Employees | Employees 635% increase | Employees 1438% increase | Employees 17423% increase |
Valuation ($) | Valuation ($) 4.1 m | Valuation ($) 116.2 m | Valuation ($) 7.5 m |
Financial | |||
Net income | Net income ($64.8m) (FY, 2022) | Net income ($116.8m) (FY, 2025) | Net income ($179.7m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 135m | Total funding raised $ 145.6m | Total funding raised $ 245m |

Adicet Bio is a biotechnology company that develops therapies for cancer diseases.
View company
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
View company